Related Experiment Video
Updated: Jun 15, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients
P E Hickman1, D A McGill, G Talaulikar
1Department of Chemical Pathology, The Canberra Hospital and Department of Pathology, ANU Medical School, Canberra, Australian Capital Territory, Australia. peter.hickman@act.gov.au
Insights
In end-stage renal disease patients on dialysis, N-terminal pro-BNP (NT-pro-BNP) is a stronger predictor of mortality than troponin T (TnT) and troponin I (TnI). This finding aids in assessing cardiovascular risk in this vulnerable population.
Area of Science:
- Cardiology
- Nephrology
- Biomarker Research
Background:
- Cardiovascular mortality is high in end-stage renal disease (ESRD) patients.
- Established cardiac biomarkers include troponin T (TnT), troponin I (TnI), B-type natriuretic peptide (BNP), and N-terminal pro-BNP (NT-pro-BNP).
Purpose of the Study:
- To evaluate the prognostic significance of TnT, TnI, BNP, and NT-pro-BNP in ESRD patients.
- To compare the predictive value of these cardiac biomarkers for all-cause mortality in dialysis patients.
Main Methods:
- Prospective cohort study of 143 dialysis patients in Australia.
- Collected clinical and biochemical data, including cardiac biomarkers.
- Followed patients for a median of 30 months to record all-cause mortality.
- Utilized Cox proportional hazards analysis to assess covariate-outcome relationships.
Main Results:
- All tested cardiac markers (TnT, TnI, BNP, NT-pro-BNP) were associated with increased mortality in univariate analysis.
- Multivariate Cox analysis identified only albumin and NT-pro-BNP as significant predictors of mortality.
- NT-pro-BNP demonstrated a significant association with mortality (Hazard Ratio: 1.585, P = 0.004).
Conclusions:
- N-terminal pro-BNP (NT-pro-BNP) offers superior prognostic information for mortality in ESRD patients on dialysis compared to TnT and TnI.
- Albumin also showed prognostic value in this patient cohort.
Background:
The high prevalence of cardiovascular mortality in the end-stage renal disease population is well established. The aim of this current study was to document the relative prognostic significance of established cardiac biomarkers troponin T (TnT), troponin I (TnI), B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-pro-BNP) in this population.
Methods:
A prospective cohort study of dialysis patients undertaken in a single tertiary centre in Australia. Relevant clinical and biochemical information was collected at entry and all patients followed up prospectively without any loss to follow up. End-point of interest was all-cause mortality. Statistical analysis using Cox proportional hazards was used to study relationship between competing covariates and outcome. A total of 143 patients with a mean age of 59.67 +/- 15.49 years was followed up for a median duration of 30 months. Of these patients, 89.3% were white Australians of European ancestry. Twenty-seven per cent had an established diagnosis of diabetes mellitus. The mean concentrations (+/-SD) of TnT, TnI, BNP and N-terminal peptide pro-BNP (NT-pro-BNP) were 0.08 +/- 0.04 microg/L, 0.09 +/- 0.2 microg/L, 270 +/- 117 ng/L and 1434 +/- 591 ng/L respectively.
Results:
Twenty-eight subjects died during the period of follow up. By univariate analysis, all cardiac markers (TnT, TnI, BNP, NT-pro-BNP and C-reactive protein) were significantly associated with an increase in mortality. On Cox proportionate hazards analysis, only albumin and NT-pro-BNP showed a significant association with mortality, with hazard ratios of 0.834, 95% confidence interval (CI) 0.779-0.893, P < 0.001, and 1.585, 95%CI 1.160-20165, P = 0.004 respectively.
Conclusion:
In patients with end-stage renal failure on dialysis NT-pro-BNP provides greater prognostic information compared with TnT and TnI.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Chronic Kidney Disease III: Interprofessional Care
Heart Failure V: Medical Management